Background-Apoptosis of vascular endothelial cells (ECs
A poptosis of vascular endothelial cells (ECs) is considered important in the development and progression of atherosclerosis. [1] [2] [3] Induction of EC apoptosis by experimentally oxidized LDL (oxLDL) is one among several mechanisms by which modified LDL can exert proatherogenic effects. 4 -9 Electronegative human LDL, LDL(Ϫ), has been found in vitro to be proinflammatory and cytotoxic to ECs, as reported by Demuth et al 10 and others. [11] [12] [13] Because induction of apoptosis by circulating LDL has not been demonstrated previously, we sought to elucidate the mechanism of apoptosis in vascular ECs treated by an electronegative LDL species similar to LDL(Ϫ).
Using fast protein liquid chromatography (FPLC), we described a range of human plasma LDL subfractions, L 1 -L 5 . Marked apoptosis was induced in cultured bovine aortic ECs (BAECs) by L 5 , the most electronegative LDL subfraction isolated from hypercholesterolemic plasma. L 4 of hypercholesterolemic plasma induced mild apoptosis. Sufficient L 4 and L 5 could not be isolated from normolipidemic samples for further assays. L 1 -L 3 , whether prepared from hypercholesterolemic or normocholesterolemic plasma, did not induce BAEC apoptosis.
Mechanisms for the induction of vascular EC apoptosis by LDL in hypercholesterolemic plasma remain poorly defined.
L 5 , by far the most proapoptotic subfraction, was also the only subfraction to exhibit appreciable oxidation. This observation lends support to the relevance of in vivo oxidation as a pathogenic mechanism of atherosclerosis. 4, 14 In the present studies, we investigated the fibroblast growth factor 2 (FGF-2) and platelet-activating factor (PAF) receptor (PAFR) pathways. FGF-2 is a pro-cell survival and antiapoptotic peptide, [15] [16] [17] although the molecular sequences linking its expression and the regulation of apoptosis have not been established. Phospholipids derived from LDL modification have been shown to be atherogenic 5,6,18 -20 ; most of them exert PAF-like effects by means of PAFR, a heptahelical receptor coupled to G i proteins. 18, 21 Because PAF-like lipids evoke calcium influx via the PAFR in cultured human polymorphonuclear neutrophils (PMNs), 5 a useful bioassay of L 5 is to monitor intracellular calcium in PMNs treated with L 5 lipid extract.
Methods

Cells and LDL Preparations
The experiments were performed in primary BAEC cultures of 6 to 10 passages, maintained in DMEM supplemented with 10% FBS and antibiotics. 22 LDL particles (dϭ1.019 to 1.063 g/mL) from pooled human plasma anticoagulated with EDTA (0.5 mg/mL) were isolated by sequential ultracentrifugation. For oxLDL preparation, LDL was exposed at 37°C for 24 hours to 5 mol/L CuSO 4 in PBS. After the incubation was terminated by EDTA (0.5 mg/mL), the preparation was dialyzed and preserved in nitrogen-filled tubes. Precautions were taken to prevent endotoxin contamination. 23 
LDL Subfractions
Blood samples were obtained from 7 hypercholesterolemic patients (LDL-C, 4.82Ϯ0.62 mmol/L [188Ϯ22 mg/dL], meanϮSEM) and 7 healthy, normolipidemic subjects (LDL-C, 2.75Ϯ0.36 mmol/L [107Ϯ14 mg/dL], PϽ0.01) with described methods designed to protect against ex vivo oxidation and coagulation. 24 Fasting plasma triglyceride was Ͻ2.0 mmol/L (180 mg/dL) in all subjects. None of the study subjects (male-to-female ratio, 3:4; age, 30 to 48 years in both groups) had a history of smoking, diabetes mellitus, atherosclerotic clinical manifestations, hypertension, or any other systemic disease.
Ultracentrifugal LDL preparations were chromatographed with an ion-exchange FPLC system (Pharmacia Biotech Co) through a UnoQ12 column (BioRad) that had been equilibrated with buffer A (0.02 mol/L Tris-HCl, pH 8.0, containing 1 mmol/L EDTA). Subfractions were eluted by use of a multistep gradient of buffer B (1 mol/L NaCl in buffer A). Samples equilibrated with buffer A were eluted with a linear gradient program at a flow rate of 2 mL/min. Effluent was monitored at 280 nm and protected from ex vivo oxidation with 5 mmol/L EDTA. Protein concentrations were determined by the Lowry method. Thiobarbituric acid-reactive substances (TBARS) were assayed as a measure of oxidative lipid modification. 23 To assess the propensity of LDL preparations to oxidative modification, LDL subfractions and unfractionated normolipidemic LDL were exposed to 5 mol/L Cu 2ϩ and their oxidation kinetics assessed by continuous monitoring of the formation of conjugated dienes at 234 nm. 25 
Apoptosis Assays
Subconfluent cultures, washed by and maintained in DMEM containing 5% serum, were exposed to PBS (lipoprotein-free, negative control) or graded (25, 50 , and 100 g/mL) LDL subfractions, unfractionated normolipidemic LDL, and Cu 2ϩ -oxLDL for 6, 12, or 24 hours. Actinomycin D (30 ng/mL) was used as a positive control for apoptosis induction. Treated cells were stained for 10 minutes with 1 mol/L Hoechst 33342 (Molecular Probes) to assess nuclear morphology and with calcein acetoxymethyl ester and propidium iodide (Molecular Probes) to assess membrane integrity. Epifluorescence imaging (500 cells/well) was performed using a Zeiss inverted microscope (Axiovert; ϫ400) with MetaView software (Universal Imaging Corp) in triplicate. 26 DNA laddering was evaluated by a cell death detection assay (Boehringer-Mannheim). 26 
Northern Blot Analysis and ELISA
To measure FGF-2 mRNA, 50 g total RNA isolated from cultured cells was subjected to electrophoresis in each lane of 1% agarose/2.2 mol/L formaldehyde gel and transferred to Nytran membranes (Schleicher & Schuell). The FGF-2 cDNA insert was excised from plasmid constructs with EcoRI and gel-purified (Geneclean Kit, Bio 101, Inc) for use as a template. Northern blot analysis was performed, and FGF-2 mRNA level was determined by a PhosphorImager and normalized to ␤-actin standards as described previously. 22 To determine the intracellular FGF-2 concentration, ELISA was performed in cell lysates by use of a Quantikine kit (R&D Systems), and FGF-2 was estimated spectrophotometrically at 450 nm. 22, 23 Nuclear Run-On Analysis
The effects of LDL subfractions on FGF-2 transcription were assessed by nuclear run-on analysis. Nuclei of treated cells were isolated with NP-40 lysis buffer (10 mmol/L Tris-HCl at pH 7.4, 10 mmol/L NaCl, 3 mmol/L MgCl 2 , 0.5% NP-40) and stored at Ϫ80°C before use. Nuclei from 5ϫ10 7 cells in 100 L of storage buffer were used for the transcription assay after thawing and incubation in 100 L of 2ϫ reaction buffer and 100 Ci of [␣- 32 P]UTP at 30°C for 30 minutes. To remove template DNA after transcription, RNase-free DNase I and 1 mol/L CaCl 2 were added to the mixture, which was incubated at 26°C for 30 minutes. To digest protein in the mixture, 10ϫ SET, proteinase K, and tRNA (Roche) were added to the mixture before incubation at 37°C for 30 minutes. The labeled nascent RNA transcripts were isolated with Tri-Reagent (Molecular Research Center) plus chloroform and precipitated with isopropanol. Pellets were washed with 70% ice-cold ethanol and dissolved in 0.2% SDS. To detect newly synthesized RNA, 1 g FGF-2 and 1 g ␤-actin (control) cDNAs were immobilized separately onto nitrocellulose, prehybridized in hybridization buffer (Amersham-Pharmacia), and hybridized at 65°C for 24 hours with labeled nascent RNA transcripts from each experiment. The membranes were then washed twice with 2ϫ SSC at 65°C for 20 minutes and exposed to x-ray film for 24 hours.
rPAF-AH Treatment, PAFR Inactivation, and FGF-2 Supplementation
To determine whether PAF-like lipids play a mediator role, some LDL subfractions were pretreated with 200 g/mL of a recombinant PAF-acetylhydrolase (rPAF-AH; gift from ICOS) for 1 hour at 37°C before being added to cell cultures. The control treatment was the solution (sodium citrate, sucrose, pluronic, and Tween 80) used for rPAF-AH formulation. To determine whether the apoptotic signal was mediated through receptors with PAFR characteristics, cells were treated with the PAFR blocker WEB-2086 (10 mol/L; gift from Boehringer Ingelheim) for 1 hour before incubation with LDL preparations. 27 Because such receptors may be coupled to G i proteins, some cultures were pretreated with 100 ng/mL of the G i deactivator pertussis toxin (PTX; Calbiochem) for 18 hours. 27 To test whether FGF-2 prevents apoptosis induced by LDL preparations, some cultures were simultaneously supplemented with exogenous FGF-2 (10 ng/mL). 23 
Bioassay of L 5 Lipid Using Fura 2 AM-Loaded PMNs
Human PMNs were isolated by dextran sedimentation and centrifugation over Ficoll and labeled with calcium-sensitive fura 2-AM as described previously. 5, 28 Lipids were extracted from hypercholesterolemic L 5 by the Bligh-Dyer method and suspended in HBSS containing 0.5% albumin. 28 Intracellular calcium was then monitored in labeled PMNs before and after treatment with PAF (Biomol), L 5 lipid, and L 5 lipid pretreated with rPAF-AH.
Statistical Analysis
The significance of differences was assessed by a paired Student's t test with Bonferroni correction. Probability values of PϽ0.05 were considered significant. Results are expressed as meanϮSEM values.
Results
LDL Subfractions
In all hypercholesterolemic LDL samples, FPLC yielded a full spectrum of continuous peaks. Because their individual amounts were inadequate for cell culture experiments, the peaks were grouped into 5 subfractions according to the following elution profile: L 1 (eluting tubes 11 to 14), L 2 (15 and 16), L 3 (17 to 24), L 4 (25 to 30), and L 5 (31 to 40). Electronegativity increased in the direction L 1 to L 5 . In the normolipidemic samples, L 4 and L 5 were either not detectable or insufficient for apoptosis assays (Figure 1) . TBARS values were Ͻ2 nmol/mg LDL protein for hypercholesterolemic L 1 -L 4 (nϭ7) and normolipidemic L 1 -L 3 (nϭ7), 2 to 4 nmol/mg for L 5 (nϭ7), and 18 to 22 nmol/mg for Cu 2ϩ -oxLDL (nϭ5), indicating no oxidation, mild oxidation, and full oxidation. Oxidation profiles assayed by diene formation, however, revealed a shorter inhibition period and greater maximal propagation rate for L 5 compared with hypercholesterolemic L 1 and unfractionated normolipidemic LDL (Figure 2 ).
Effects of Hypercholesterolemic and Normolipidemic LDL Subfractions on EC Apoptosis
At 24 hours and an LDL concentration of 50 g/mL, unfractionated normolipidemic LDL induced, as assessed by epifluorescence microscopy, negligible apoptosis: 2Ϯ1% (nϭ7), a value not different from those for L 1 , L 2 , and L 3 from hypercholesterolemic patients (nϭ7; Figure 3 ) or normolipidemic subjects (nϭ7; data not shown). Hypercholesterolemic L 4 and L 5 , however, provoked significantly more apoptosis-10Ϯ4% (PϽ0.05) and 36Ϯ8% (PϽ0.001)-than normolipidemic LDL. L 5 exceeded L 4 (PϽ0.01) and approximated Cu 2ϩ -oxLDL (41Ϯ10%) in apoptotic potency ( Figure 3 ). Unlike L 1 -L 3 , the apoptotic effects of L 4 and L 5 were concentration dependent and time dependent. At 24 hours, 25 g/mL of either yielded less apoptosis than 50 g/mL, and 100 g/mL of L 5 induced Ͼ50% apoptosis. Highconcentration L 5 (100 g/mL) yielded a higher percentage (Ͼ5% to Ϸ7%) of cells with membrane disruption; at 50 g/mL for 24 hours, almost all cells undergoing apoptotic changes maintained membrane integrity: Ͻ2% exhibited a disrupted membrane. At 50 g/mL, L 5 -induced apoptosis started to manifest in a few cells at 12 hours, became prominent at 16 hours, and plateaued at 24 hours. For consistency, all subsequent experiments were performed in cultures incubated for 24 hours with 50 g/mL of LDL preparations.
L 5 and FGF-2 Transcription
As seen by Northern blot analysis, both L 5 and Cu 2ϩ -oxLDL decreased FGF-2 mRNA by 50%-60% compared with PBS and unfractionated normolipidemic LDL ( Figure 4A ). Intracellular FGF-2 concentration averaged 306Ϯ26 and 182Ϯ32 pg/mg in cells exposed to hypercholesterolemic L 1 and L 5 , 
Effect of L 5 Lipid Extract on Calcium Influx in Human PMNs
PAF evoked calcium influx in fura 2-AM-loaded PMNs in a concentration-dependent manner (data not shown). Lipid extracted from L 5 (containing 75 g protein) induced a rapid rise in intracellular calcium ( Figure 8A ). After treatment with rPAF-AH (8 g) at 37°C for 3 hours, the lipid extract became completely inactive. The PMNs remained responsive, however, to exogenously added PAF ( Figure 8B ).
Discussion
Our findings indicate that a highly electronegative LDL subfraction, L 5 , present in native hypercholesterolemic human plasma (but not collectible in normolipidemic plasma) induced marked apoptosis in cultured vascular ECs. The proapoptotic effect of L 5 confirms the important findings of Demuth et al 10 that LDL(Ϫ) is cytotoxic to ECs. The apoptotic effect was equivalent to that of Cu 2ϩ -oxLDL. Our further studies showed that L 5 induced apoptosis through downregulation of FGF-2 at the transcriptional level, which may be the first report of transcriptional modulation of a gene by a lipoprotein without its ex vivo modification. When added to a variety of cell types, FGF-2 stimulates phosphoinositol-3-kinase (PI3K), which in turn activates Akt (protein kinase B). 29 Akt inhibits apoptosis by deactivating downstream targets such as BAD and forkhead transcription factor. 29, 30 We previously showed that Cu 2ϩ -oxLDL downregulates endothelial FGF-2 by increasing posttranscriptional destabilization. 22 After pretreatment with rPAF-AH, L 5 lost the ability to inhibit FGF-2 transcription and was no longer proapoptotic. Supplementation with FGF-2 compensated for the endogenous deficit and prevented apoptosis in L 5 -exposed cells. These findings strongly indicate that intact FGF-2 transcription is prerequisite to EC survival. PAF-AH is a phospholipase A 2 -like enzyme that specifically hydrolyzes the acetyl residue of PAF or the various truncated and/or oxidized sn-2 residues of PAF-like lipids. 31 Such phospholipids with a butanoyl/butenyl moiety, 5 glutaroyl or oxovaleroyl moiety, 6, 32 or azelaoyl moieties 33 have been reported to be present in experimentally oxidized LDL. In oxLDL, they may act through PAFR or a receptor similar to PAFR in a manner sensitive to the PAFR antagonist WEB-2086 and PAF-AH treatments. In the present study, EC apoptosis induced by L 5 was greatly attenuated by WEB-2086. In addition, it was attenuated by PTX, a deactivator of G i proteins coupled to PAFR. 27, 34 The finding that L 5 lipid-induced calcium influx in human PMNs was sensitive to rPAF-AH pretreatment strongly implicates PAF-like lipids. These findings indicate that oxysterols 7 and phospholipids without an sn-2 moiety, such as lyso-phosphatidylcholine and lyso-PAF, 28 are unlikely to play an important mediator role. We showed previously that synthetic PAF-16 does not inhibit FGF-2 expression or EC proliferation. 27 The present data suggest that lipids with PAF-like structures in L 5 (but not PAF per se) mediate the signaling that is transduced by G i -coupled membrane receptors sensitive to WEB-2086.
L 5 was only mildly oxidized but produced conjugated dienes at a higher rate than the other hypercholesterolemic subfractions and unfractionated normolipidemic LDL. Such a propensity for further oxidation may or may not play a role in L 5 bioactivities: conjugated diene formation was registered only when EDTA (added to preparations to prevent ex vivo oxidation) had been removed by dialysis. In all cell culture experiments, EDTA was not removed from the LDL preparations. In previous studies by other investigators, in which LDL was classified as LDL(ϩ) or LDL(Ϫ), no evidence of peroxidative modifications was seen in electronegative LDL subfractions isolated from normolipidemic subjects. 10,11 LDL(Ϫ) isolated from normolipidemic human plasma may or may not produce more conjugated dienes than LDL(ϩ). 11, 13 In hypercholesterolemic human plasma, Sevanian et al 12 found significantly higher conjugated dienes in LDL(Ϫ) than in LDL(ϩ). The proinflammatory and cytotoxic effects of LDL(Ϫ) on ECs included release of interleukin 8, monocyte chemotactic protein, and lactate dehydrogenase. 13 The possibility that L 5 bioactivity was a result of ex vivo oxidation can be ruled out with a high degree of confidence. All subfractions were processed using the same protocol with antioxidation precautions. LDL mildly oxi- 
